Release
📈 Stocks
ERS Genomics Grants CRISPR/Cas9 Licensing Rights to KU Leuven
(just now)
ERS Genomics expands its CRISPR licensing footprint by providing KU Leuven's Viral Vector Core with essential intellectual property to advance global genome…